STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.

PubWeight™: 5.17‹?› | Rank: Top 1%

🔗 View Article (PMID 18218287)

Published in Int J Clin Pharmacol Ther on February 01, 2008

Authors

P Gallagher1, C Ryan, S Byrne, J Kennedy, D O'Mahony

Author Affiliations

1: Department of Geriatric Medicine, Cork University Hospital, Wilton, Cork, Ireland.

Associated clinical trials:

Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients | NCT01467050

Inappropriate Prescription in Elderly and Polypharmacy Patients in Primary Care (PHARM-PC) Trial (PHARM-PC) | NCT02224833

Articles citing this

(truncated to the top 100)

Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54

Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc (2012) 4.04

Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int (2010) 3.94

Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc (2012) 3.84

Guidelines for pharmacists integrating into primary care teams. Can Pharm J (Ott) (2013) 3.05

STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing (2014) 2.56

International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol (2014) 2.13

Adverse drug events in older patients admitted as an emergency: the role of potentially inappropriate medication in elderly people (PRISCUS). Dtsch Arztebl Int (2013) 2.06

Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol (2010) 2.04

Inappropriate prescribing and adverse drug events in older people. BMC Geriatr (2009) 1.66

Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol (2009) 1.59

Development of prescribing-safety indicators for GPs using the RAND Appropriateness Method. Br J Gen Pract (2011) 1.54

Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014). Age Ageing (2015) 1.44

Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol (2012) 1.40

Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians. Ann Fam Med (2016) 1.40

Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One (2012) 1.38

Recommendations to support deprescribing medications late in life. Int J Clin Pharm (2015) 1.37

Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol (2011) 1.35

Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc (2014) 1.31

The next therapeutic challenge in HIV: polypharmacy. Drugs Aging (2013) 1.30

Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol (2013) 1.29

Rationalizing prescribing for older patients with multimorbidity: considering time to benefit. Drugs Aging (2013) 1.26

Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging (2010) 1.25

Polypharmacy in older adults with cancer. Oncologist (2010) 1.23

Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. BMC Clin Pharmacol (2012) 1.22

Polypharmacy: one of the greatest prescribing challenges in general practice. Br J Gen Pract (2011) 1.19

Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization--analyses from a randomized controlled trial. PLoS One (2013) 1.18

Potentially inappropriate medications and risk of hospitalization in retirees: analysis of a US retiree health claims database. Drugs Aging (2010) 1.14

Prescription pattern and prevalence of potentially inappropriate medications among elderly patients in a Nigerian rural tertiary hospital. Ther Clin Risk Manag (2013) 1.12

Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. Br J Clin Pharmacol (2014) 1.11

The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging (2013) 1.10

Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatr (2014) 1.08

Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list. Wien Klin Wochenschr (2011) 1.08

Adverse drug reactions in special populations - the elderly. Br J Clin Pharmacol (2015) 1.07

Identification of an updated set of prescribing--safety indicators for GPs. Br J Gen Pract (2014) 1.05

Routine deprescribing of chronic medications to combat polypharmacy. Ther Adv Drug Saf (2015) 1.04

Developing a complex intervention to improve prescribing safety in primary care: mixed methods feasibility and optimisation pilot study. BMJ Open (2014) 1.03

Addressing potentially inappropriate prescribing in older patients: development and pilot study of an intervention in primary care (the OPTI-SCRIPT study). BMC Health Serv Res (2013) 1.02

Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA). Eur J Clin Pharmacol (2014) 1.02

Developing consensus on hospital prescribing indicators of potential harms amenable to decision support. Br J Clin Pharmacol (2013) 1.00

Inappropriate prescribing for the elderly--a modern epidemic? Eur J Clin Pharmacol (2012) 1.00

Association between Potentially Inappropriate Medication (PIM) Use and Risk of Hospitalization in Older Adults: An Observational Study Based on Routine Data Comparing PIM Use with Use of PIM Alternatives. PLoS One (2016) 0.99

Ten-year trajectory of potentially inappropriate medications in very old women: importance of cognitive status. J Am Geriatr Soc (2013) 0.98

The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol (2015) 0.97

Potentially inappropriate medications in a large cohort of patients in geriatric units: association with clinical and functional characteristics. Eur J Clin Pharmacol (2012) 0.96

Identifying high-risk medication: a systematic literature review. Eur J Clin Pharmacol (2014) 0.96

Effects of drug pharmacokinetic/pharmacodynamic properties, characteristics of medication use, and relevant pharmacological interventions on fall risk in elderly patients. Ther Clin Risk Manag (2014) 0.95

Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging (2014) 0.95

Deprescribing: a new word to guide medication review. CMAJ (2014) 0.94

Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people. Eur J Clin Pharmacol (2015) 0.94

Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records: A Cross-Sectional Study. Drug Saf (2015) 0.93

Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open (2015) 0.93

National indicators for quality of drug therapy in older persons: the Swedish experience from the first 10 years. Drugs Aging (2015) 0.92

Trends in inappropriate drug therapy prescription in the elderly in Sweden from 2006 to 2013: assessment using national indicators. Drugs Aging (2014) 0.91

Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open (2015) 0.90

[The PRISCUS list in clinical routine. Practicability and comparison to international PIM lists]. Z Gerontol Geriatr (2013) 0.89

Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. Br J Clin Pharmacol (2011) 0.89

The use of START/STOPP criteria for elderly patients in primary care. ScientificWorldJournal (2013) 0.88

Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages. Eur J Clin Pharmacol (2011) 0.88

Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method. BMJ Open (2012) 0.88

Commentary on the new American Geriatric Society Beers criteria for potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother (2012) 0.87

Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards. Scand J Prim Health Care (2012) 0.87

Computerized Decision Support Improves Medication Review Effectiveness: An Experiment Evaluating the STRIP Assistant's Usability. Drugs Aging (2015) 0.87

Cumulative Cardiovascular Polypharmacy Is Associated With the Risk of Acute Kidney Injury in Elderly Patients. Medicine (Baltimore) (2015) 0.86

Drug Burden Index in older adults: theoretical and practical issues. Clin Interv Aging (2014) 0.86

Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study. Eur J Clin Pharmacol (2015) 0.85

Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study. Wien Klin Wochenschr (2013) 0.85

Discontinuing inappropriate medication in nursing home residents (DIM-NHR Study): protocol of a cluster randomised controlled trial. BMJ Open (2014) 0.85

Clinical pharmacology in old persons. Scientifica (Cairo) (2012) 0.85

Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related? Eur J Clin Pharmacol (2014) 0.85

The development of the PROMPT (PRescribing Optimally in Middle-aged People's Treatments) criteria. BMC Health Serv Res (2014) 0.84

An investigation into drug-related problems identifiable by commercial medication review software. Australas Med J (2013) 0.84

Effects of "Fit fOR The Aged" (FORTA) on pharmacotherapy and clinical endpoints--a pilot randomized controlled study. Eur J Clin Pharmacol (2014) 0.84

[Management and therapy of atrial fibrillation in geriatric patients]. Z Gerontol Geriatr (2012) 0.84

The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis. Br J Clin Pharmacol (2015) 0.84

Drug-related emergency department visits by elderly patients presenting with non-specific complaints. Scand J Trauma Resusc Emerg Med (2013) 0.83

How to implement a geriatric assessment in your clinical practice. Oncologist (2014) 0.82

Improving psychotropic drug prescription in nursing home patients with dementia: design of a cluster randomized controlled trial. BMC Psychiatry (2013) 0.82

The effect of pharmacist-led interventions in optimising prescribing in older adults in primary care: A systematic review. SAGE Open Med (2016) 0.82

Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database. Eur J Clin Pharmacol (2014) 0.82

The impact of a medication review with follow-up service on hospital admissions in aged polypharmacy patients. Br J Clin Pharmacol (2016) 0.82

Polypharmacy and incontinence. Z Gerontol Geriatr (2012) 0.81

Medication Underuse in Aging Outpatients with Cardiovascular Disease: Prevalence, Determinants, and Outcomes in a Prospective Cohort Study. PLoS One (2015) 0.81

Potentially inappropriate prescribing in older primary care patients. PLoS One (2014) 0.81

Content validation of a tool for assessing risks for drug-related problems to be used by practical nurses caring for home-dwelling clients aged ≥65 years: a Delphi survey. Eur J Clin Pharmacol (2014) 0.81

Potentially inappropriate prescribing in institutionalised older patients in Spain: the STOPP-START criteria compared with the Beers criteria. Pharm Pract (Granada) (2012) 0.81

Detection of potentially inappropriate prescribing in the very old: cross-sectional analysis of the data from the BELFRAIL observational cohort study. BMC Geriatr (2015) 0.81

Deprescription: The prescription metabolism. J Pharmacol Pharmacother (2016) 0.80

Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many. Drug Saf (2016) 0.80

Potentially inappropriate prescribing to the elderly: comparison of new protocol to Beers criteria with relation to hospitalizations for ADRs. Eur J Clin Pharmacol (2014) 0.80

A tool for prediction of risk of rehospitalisation and mortality in the hospitalised elderly: secondary analysis of clinical trial data. BMJ Open (2015) 0.80

POPI (Pediatrics: Omission of Prescriptions and Inappropriate prescriptions): development of a tool to identify inappropriate prescribing. PLoS One (2014) 0.80

Comprehensive geriatric assessment in the emergency department. Clin Interv Aging (2014) 0.80

A standardized, bundled approach to providing geriatric-focused acute care. J Am Geriatr Soc (2014) 0.80

Why do family doctors prescribe potentially inappropriate medication to elderly patients? BMC Fam Pract (2016) 0.80

Barricades and brickwalls - a qualitative study exploring perceptions of medication use and deprescribing in long-term care. BMC Geriatr (2016) 0.80

Potentially inappropriate medications in the elderly: a comprehensive protocol. Eur J Clin Pharmacol (2012) 0.80

Potential utility of precision medicine for older adults with polypharmacy: a case series study. Pharmgenomics Pers Med (2016) 0.80

Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a cross-sectional population based study. BMC Geriatr (2016) 0.80

Development of the Tool to Reduce Inappropriate Medications (TRIM): A Clinical Decision Support System to Improve Medication Prescribing for Older Adults. Pharmacotherapy (2016) 0.80

Articles by these authors

Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus. J Clin Microbiol (1994) 9.16

A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol (1993) 4.44

Multiple dopamine D4 receptor variants in the human population. Nature (1992) 4.08

Residential culturable fungi, (1-3, 1-6)-β-d-glucan, and ergosterol concentrations in dust are not associated with asthma, rhinitis, or eczema diagnoses in children. Indoor Air (2013) 3.27

Lymphotactin: a cytokine that represents a new class of chemokine. Science (1994) 2.74

Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis (1997) 2.65

Post-traumatic stress disorder. Br J Psychiatry (1989) 2.57

Expression of proteinase inhibitors I and II in transgenic tobacco plants: effects on natural defense against Manduca sexta larvae. Proc Natl Acad Sci U S A (1989) 2.53

Autosomal dominant retinitis pigmentosa (ADRP): localization of an ADRP gene to the long arm of chromosome 3. Genomics (1989) 2.52

A survey to identify the clinical coding and classification systems currently in use across Europe. Stud Health Technol Inform (2001) 2.41

Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8- thymocyte differentiation. J Immunol (1994) 2.38

Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology (2007) 2.32

Infliximab for refractory ulcerative colitis. Am J Gastroenterol (2001) 2.26

Enzymic and substrate basis for the anaplerotic step in guard cells. Plant Physiol (1978) 2.24

Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther (2011) 2.22

Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res (1996) 2.22

Detection of hypoglycemia with the GlucoWatch biographer. Diabetes Care (2001) 2.20

Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis (1982) 2.20

Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene (1996) 2.20

Simulated home delivery in hospital: a randomised controlled trial. Br J Obstet Gynaecol (1993) 2.16

National Lesbian Health Care Survey: implications for mental health care. J Consult Clin Psychol (1994) 2.13

Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis (1993) 2.07

Scapulothoracic motion in normal shoulders and shoulders with glenohumeral instability and impingement syndrome. A study using Moiré topographic analysis. Clin Orthop Relat Res (1992) 2.07

Inappropriate prescribing in the elderly. J Clin Pharm Ther (2007) 2.03

Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius. Nat Biotechnol (1998) 1.97

Characterization of factors that direct transcription of rat ribosomal DNA. Mol Cell Biol (1990) 1.93

Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol (1998) 1.92

Patterns of flexibility, laxity, and strength in normal shoulders and shoulders with instability and impingement. Am J Sports Med (1990) 1.83

START (screening tool to alert doctors to the right treatment)--an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing (2007) 1.80

Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50. J Exp Med (1998) 1.79

Voluntary, named testing for HIV in a community based antenatal clinic: a pilot study. BMJ (1995) 1.78

Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol (1991) 1.76

Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation (1996) 1.76

Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet (1992) 1.76

Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators. Eur J Heart Fail (1999) 1.75

Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics (1985) 1.74

Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin Exp Allergy (2010) 1.73

A closer look at water-related geologic activity on Mars. Science (2007) 1.71

Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology (2009) 1.70

Etiology of childhood diarrhea in Beijing, China. J Clin Microbiol (1991) 1.70

Incidence of acquired demyelination of the CNS in Canadian children. Neurology (2009) 1.63

Mediating the cultural boundaries between medicine, nursing and management--the central challenge in hospital reform. Health Serv Manage Res (2001) 1.61

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther (2013) 1.59

Risk factors for asthma symptoms in Kawerau children. N Z Med J (1994) 1.56

British HIV Association guidelines for the management of HIV infection in pregnant women 2012. HIV Med (2012) 1.54

Cardiac abnormalities in poisoning with tricyclic antidepressants. Br Med J (1969) 1.50

Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology (2011) 1.49

Mesh erosion into the urinary bladder following laparoscopic inguinal hernia repair; is this the tip of the iceberg? Hernia (2009) 1.49

Mild pyelectasis ascertained with prenatal ultrasonography is pediatrically significant. Ultrasound Obstet Gynecol (1997) 1.48

Coronary rotational ablation: initial experience in 302 procedures. J Am Coll Cardiol (1993) 1.47

Multiple inflow pulsed arterial spin-labeling reveals delays in the arterial arrival time in minor stroke and transient ischemic attack. AJNR Am J Neuroradiol (2010) 1.47

Xanthogranulomatous cholecystitis. J Am Coll Surg (1994) 1.47

Febrile urinary infection in the institutionalized elderly. Am J Med (1996) 1.47

The financial implications of falls in older people for an acute hospital. Ir J Med Sci (2006) 1.46

Dopamine genes and ADHD. Neurosci Biobehav Rev (2000) 1.46

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Simultaneous carotid endarterectomy and coronary artery bypass surgery in Canada. Neurology (2005) 1.41

Urinary antibody level and survival in bacteriuric institutionalized older subjects. J Am Geriatr Soc (1998) 1.40

Student dept. Banks refuse loans. Nurs Times (2002) 1.40

Nitric oxide in acute ischaemic stroke: a target for neuroprotection. J Neurol Neurosurg Psychiatry (1999) 1.40

Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology (2005) 1.39

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Injuries in Rugby League football. Med J Aust (1979) 1.39

Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care (2011) 1.38

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol (2001) 1.34

The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology (2006) 1.33

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Extracorporeal pig-liver perfusoon in treatment of hepatic coma due to fulminant hepatitis. Lancet (1971) 1.31

Rugby league football injuries over two competition seasons. Med J Aust (1980) 1.30

Lesion morphology and coronary angioplasty: current experience and analysis. J Am Coll Cardiol (1992) 1.28

A cross-national study of differences in the identities of nursing in England and Australia and how this has affected nurses' capacity to respond to hospital reform. Nurs Inq (2000) 1.28

Hereditary mental depression and Parkinsonism with taurine deficiency. Arch Neurol (1975) 1.25

Congenital syphilis in the Russian Federation: magnitude, determinants, and consequences. Sex Transm Infect (2003) 1.24

A comparison of the impact of hospital reform on medical subcultures in some Australian and New Zealand hospitals. Aust Health Rev (1999) 1.24

Occupational predictors of pregnancy outcomes in Irish working women in the Lifeways cohort. BJOG (2009) 1.23

Cognitive loss and recovery in long-term alcohol abusers. Arch Gen Psychiatry (1983) 1.23

Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis. N Engl J Med (1976) 1.22

The nature of the chromophore responsible for naturally occurring fluorescence in mouse skin. J Photochem Photobiol B (1988) 1.21

Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements. N Engl J Med (1981) 1.20

Cardiorespiratory responses to exercise training after orthotopic cardiac transplantation. Circulation (1988) 1.19

Oxygen cost of running barefoot vs. running shod. Int J Sports Med (2011) 1.18

The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat. Proc Biol Sci (1992) 1.16

Adult-onset acute leukemia and employment in the meat industry: a New Zealand case-control study. Cancer Causes Control (2001) 1.15

Seasonal erosion and restoration of Mars' northern polar dunes. Science (2011) 1.13

European Nutrition and Health Report 2009. Ann Nutr Metab (2009) 1.13

An in-frame insertion into the Sindbis virus 6K gene leads to defective proteolytic processing of the virus glycoproteins, a trans-dominant negative inhibition of normal virus formation, and interference in virus shut off of host-cell protein synthesis. Virology (1993) 1.11

Isolation of a cDNA encoding thymic shared antigen-1. A new member of the Ly6 family with a possible role in T cell development. J Immunol (1993) 1.10

Superoxide production and electron transport in mitochondrial oxidation of dihydroorotic acid. J Biol Chem (1975) 1.09

Care activities and outcomes of patients cared for by acute care nurse practitioners, physician assistants, and resident physicians: a comparison. Am J Crit Care (1998) 1.09

Cultivated epithelial-like cells and fibroblasts from amniotic fluid: their relationship to enzymatic and cytologic analysis. Am J Obstet Gynecol (1972) 1.09

Prospective study of decubitus ulcers in two long term care facilities. Can J Infect Control (1994) 1.08

Characterization of the coagulant activity of cultured human fibroblasts. Blood (1971) 1.08

Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol (1998) 1.07

Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07

A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes. Diabetologia (2008) 1.06

Effects of somatic cell count on quality and shelf-life of pasteurized fluid milk. J Dairy Sci (2000) 1.06

Doctor knowledge and attitudes to donation after cardiac death. Intern Med J (2013) 1.05